Aviva Witkover

956 total citations
16 papers, 673 citations indexed

About

Aviva Witkover is a scholar working on Immunology, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Aviva Witkover has authored 16 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Agronomy and Crop Science and 11 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Aviva Witkover's work include T-cell and Retrovirus Studies (16 papers), Animal Disease Management and Epidemiology (15 papers) and Vector-Borne Animal Diseases (11 papers). Aviva Witkover is often cited by papers focused on T-cell and Retrovirus Studies (16 papers), Animal Disease Management and Epidemiology (15 papers) and Vector-Borne Animal Diseases (11 papers). Aviva Witkover collaborates with scholars based in United Kingdom, United States and Japan. Aviva Witkover's co-authors include Charles R. M. Bangham, Alison M. Vine, Graham P. Taylor, Koichiro Usuku, Katie Jeffery, Mitsuhiro Osame, Shuji Izumo, Alun L. Lloyd, Mike Bunce and Asna A. Siddiqui and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Virology.

In The Last Decade

Aviva Witkover

16 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aviva Witkover United Kingdom 13 593 450 385 62 31 16 673
Daisuke Kodama Japan 10 912 1.5× 660 1.5× 557 1.4× 120 1.9× 26 0.8× 24 1.1k
Yasuko Sagara Japan 10 633 1.1× 437 1.0× 407 1.1× 54 0.9× 22 0.7× 33 684
Guangyong Ma Japan 10 318 0.5× 263 0.6× 252 0.7× 76 1.2× 31 1.0× 16 417
Andrea K. Thoma‐Kress Germany 13 323 0.5× 219 0.5× 197 0.5× 116 1.9× 47 1.5× 29 472
Rie Furuta Japan 7 280 0.5× 198 0.4× 193 0.5× 77 1.2× 21 0.7× 10 365
I S Chen United States 7 696 1.2× 615 1.4× 579 1.5× 66 1.1× 17 0.5× 8 798
Alison M. Vine United Kingdom 8 442 0.7× 295 0.7× 246 0.6× 22 0.4× 12 0.4× 8 475
Sébastien Alain Chevalier France 17 610 1.0× 493 1.1× 412 1.1× 179 2.9× 24 0.8× 27 813
Ken‐ichiro Etoh Japan 9 537 0.9× 423 0.9× 416 1.1× 176 2.8× 42 1.4× 12 709
Björn Albrecht United States 13 852 1.4× 686 1.5× 661 1.7× 111 1.8× 27 0.9× 13 914

Countries citing papers authored by Aviva Witkover

Since Specialization
Citations

This map shows the geographic impact of Aviva Witkover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviva Witkover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviva Witkover more than expected).

Fields of papers citing papers by Aviva Witkover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviva Witkover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviva Witkover. The network helps show where Aviva Witkover may publish in the future.

Co-authorship network of co-authors of Aviva Witkover

This figure shows the co-authorship network connecting the top 25 collaborators of Aviva Witkover. A scholar is included among the top collaborators of Aviva Witkover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviva Witkover. Aviva Witkover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yaguchi, Hiroko, et al.. (2024). The impact of HTLV-1 expression on the 3D structure and expression of host chromatin. PLoS Pathogens. 20(3). e1011716–e1011716. 2 indexed citations
2.
Rowan, Aileen, Richard Dillon, Aviva Witkover, et al.. (2020). Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis. Blood. 135(23). 2023–2032. 48 indexed citations
3.
Marçais, Ambroise, Lucy Cook, Aviva Witkover, et al.. (2020). Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma. Retrovirology. 17(1). 5–5. 20 indexed citations
4.
Melamed, Anat, Hiroko Yaguchi, Michi Miura, et al.. (2018). The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis. eLife. 7. 57 indexed citations
5.
Turpin, Jocelyn, Georges Khoury, Hai Pham, et al.. (2018). Impact of Hepatitis B Virus Coinfection on Human T-Lymphotropic Virus Type 1 Clonality in an Indigenous Population of Central Australia. The Journal of Infectious Diseases. 219(4). 562–567. 14 indexed citations
6.
Cook, Lucy, Aileen Rowan, Maria Antonietta Demontis, et al.. (2017). Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma. International Journal of Hematology. 107(3). 378–382. 12 indexed citations
7.
Rowan, Aileen, Aviva Witkover, Anat Melamed, et al.. (2016). T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells. PLoS Pathogens. 12(11). e1006030–e1006030. 22 indexed citations
8.
Melamed, Anat, Aviva Witkover, Daniel J. Laydon, et al.. (2014). Clonality of HTLV-2 in Natural Infection. PLoS Pathogens. 10(3). e1004006–e1004006. 26 indexed citations
9.
Melamed, Anat, Aviva Witkover, Brent Brown, et al.. (2014). Clonality of HTLV-2 in natural infection. Retrovirology. 11(S1). 1 indexed citations
10.
Kirk, Paul, Aviva Witkover, Charles R. M. Bangham, et al.. (2013). Balancing the Robustness and Predictive Performance of Biomarkers. Journal of Computational Biology. 20(12). 979–989. 10 indexed citations
11.
Kirk, Paul, Aviva Witkover, Alex Lewin, et al.. (2011). Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology. 8(1). 81–81. 13 indexed citations
12.
Vine, Alison M., Adrian Heaps, Angelina J. Mosley, et al.. (2004). The Role of CTLs in Persistent Viral Infection: Cytolytic Gene Expression in CD8+ Lymphocytes Distinguishes between Individuals with a High or Low Proviral Load of Human T Cell Lymphotropic Virus Type 1. The Journal of Immunology. 173(8). 5121–5129. 71 indexed citations
13.
Vine, Alison M., Aviva Witkover, Alun L. Lloyd, et al.. (2002). Polygenic Control of Human T Lymphotropic Virus Type I (HTLV‐I) Provirus Load and the Risk of HTLV‐I–Associated Myelopathy/Tropical Spastic Paraparesis. The Journal of Infectious Diseases. 186(7). 932–939. 72 indexed citations
14.
Jeffery, Katie, Asna A. Siddiqui, Mike Bunce, et al.. (2000). The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection. The Journal of Immunology. 165(12). 7278–7284. 173 indexed citations
15.
Taylor, Graham P., Sarah E. Hall, Colin Michie, et al.. (1999). Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated Myelopathy. Journal of Virology. 73(12). 10289–10295. 97 indexed citations
16.
Bangham, Charles R. M., Sarah E. Hall, Katie Jeffery, et al.. (1999). Genetic control and dynamics of the cellular immune response to the human T–cell leukaemia virus, HTLV–I. Philosophical Transactions of the Royal Society B Biological Sciences. 354(1384). 691–700. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026